ChitogenX (TSE:CHGX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
ChitogenX Inc., a pioneering firm in regenerative medicine, has concluded its virtual Annual General Meeting, successfully re-electing six director nominees and appointing Audacie Inc. as its auditor. Shareholders displayed strong confidence, with over 90.82% votes in favor of the directorate, while the company continues to enhance tissue repair through its Chitosan Based Biopolymer technology platform.
For further insights into TSE:CHGX stock, check out TipRanks’ Stock Analysis page.